DXA-based variables and osteoporotic fractures in Lebanese postmenopausal women

被引:31
|
作者
Ayoub, M. -L. [1 ]
Maalouf, G. [2 ]
Bachour, F. [2 ]
Barakat, A. [2 ]
Cortet, B. [3 ,6 ]
Legroux-Gerot, I. [3 ,6 ]
Zunquin, G. [4 ]
Theunynck, D. [4 ]
Nehme, A. [5 ]
El Hage, R. [1 ]
机构
[1] Univ Balamand, Fac Arts & Social Sci, Dept Phys Educ, El Koura, Lebanon
[2] St Joseph Univ, Fac Med, Bellevue Med Ctr, Musculoskeletal Dept, Mansourieh, Lebanon
[3] CHU Lille, Roger Salengro Hosp, Dept Rheumatol, F-59037 Lille, France
[4] ULCO, EA448, EA 4110, Dept STAPS,URePSSS, F-59383 Dunkerque 01, France
[5] Univ Balamand, St Georges Univ, Med Ctr, Dept Orthoped Surg & Traumatol, Beirut 11002807, Lebanon
[6] EA4490, F-62327 Boulogne Sur Mer, France
关键词
Dual X-ray absorptiometry; Compressive Strength Index; Femur; Fracture risk; Menopause; BONE-MINERAL DENSITY; FEMORAL-NECK STRENGTH; PREDICTS HIP FRACTURE; X-RAY ABSORPTIOMETRY; COMPOSITE INDEXES; CHILDREN; RISK; MASS; ASSOCIATION; GEOMETRY;
D O I
10.1016/j.otsr.2014.06.023
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction: The aim of this study was to assess DXA-based variables (bone mineral density, bone mineral apparent density, compressive strength index of the femoral neck and trabecular bone score) in Lebanese postmenopausal women having presented a previous fracture. Materials and methods: One thousand Lebanese postmenopausal women between 45 and 89 years participated in this study. The women were recruited by advertisements offering bone mineral density measurements at a reduced cost. Subjects with previous history of radiotherapy or chemotherapy were excluded. Informed written consent was obtained from all the participants. Results: Femoral neck compressive strength index (FN CSI) was significantly (P < 0.001) associated with the presence of fracture using a simple logistic regression (odds ratio = 0.51 [0.385-0.653]). When a multivariate logistic regression analysis was performed with the presence of fracture as a dependent variable and each of age, FN BMD and FN CSI as independent variables, only FN BMD (P = 0.005) and FN CSI (A= 0.004) were found to be associated with the presence of fracture. Conclusion: This study suggests that FN CSI is associated with history of osteoporotic fractures in postmenopausal women. The use of FN CSI in clinical practice may help to identify patients with high risk of fracture. Level of evidence: Epidemiological study, level IV. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:855 / 858
页数:4
相关论文
共 50 条
  • [21] COMPARATIVE OSTEOPOROTIC EVALUATION USING DXA AND ULTRASONOGRAPHY IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS
    Vreju, F.
    Ciurea, P.
    Rosu, A.
    Musetescu, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 164 - 164
  • [22] DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass
    S. L. Bonnick
    T. J. Beck
    F. Cosman
    M. C. Hochberg
    H. Wang
    A. E. de Papp
    [J]. Osteoporosis International, 2009, 20 : 911 - 921
  • [23] Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
    Wells, G.
    Cranney, A.
    Peterson, J.
    Boucher, M.
    Shea, B.
    Robinson, V
    Coyle, D.
    Tugwell, P.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [24] Teriparatide relief of pain in the postmenopausal women with osteoporotic vertebral fractures
    Hwang, J. S.
    Chen, J. F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S70 - S70
  • [25] Iron accumulation and its impact on osteoporotic fractures in postmenopausal women
    Cai, Hui
    Zhang, Huimei
    He, Weiting
    Zhang, Heng
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (04): : 301 - 311
  • [26] Reduction of osteoporotic fractures with risedronate in osteopenic postmenopausal women.
    Siris, ES
    Barton, IP
    McClung, MR
    Grauer, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S93 - S93
  • [27] POSTMENOPAUSAL WOMEN WITH SARCOPENIA HAVE HIGHER PREVALENCE OF OSTEOPOROTIC FRACTURES
    Zanchetta, M. B.
    Abdala, R.
    Longobardi, V. C.
    Massari, F.
    Silveira, F.
    Zanchetta, J. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S570 - S571
  • [28] Serum levels of irisin in postmenopausal women with osteoporotic hip fractures
    Liu, Kai
    Jing, Pengwei
    Liu, Zehan
    Wang, Ying
    Han, Zhu
    Wang, Youqiang
    Zheng, Zhirui
    Wu, Yue
    Wang, Tong
    Li, Yuhui
    Zhang, Hongying
    Wang, Lichun
    [J]. CYTOKINE, 2021, 148
  • [29] Teriparatide relief of pain in postmenopausal women with osteoporotic vertebral fractures
    Hwang, J. S.
    Chen, J. F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S255 - S255
  • [30] Denosumab for the Treatment of Postmenopausal Women at Increased Risk of Osteoporotic Fractures
    Bogado, Cesar E.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 395 - 402